Business idea, strategy & vision
Dicot is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs on the market.
To develop LIB-01 until clinical phase 2 studies and seek strategic alliances with major established pharmaceutical companies to enable it to become an approved drug on the world market.
Our vision is that LIB-01 will be the first choice of drug when treating erectile dysfunction and premature ejaculation for the 500 million men who are affected. Thus, taking a crucial part of the market for sexual dysfunction treatments.